We describe the clinical presentation, management, and pathologic findings in a case of osteosarcoma of the petrous apex with an atypical metastasis to the lower abdominal wall. We retrospectively reviewed the record of a 49-year-old man who was diagnosed with a rightpetrous apex lesion, which biopsy identified as a high-grade osteoblastoma. After two attempts at en bloc resection were not curative, radiation and chemotherapy were recommended. TIle patient subsequently developed a cutaneous lowerabdominal mass that was diagnosed as an osteosarcoma. Meanwhile, the petrousapex tumor continuedtogrowdespite treatmentuntil thepatientdied from theburden ofdisease. Temporal boneosteoblastomas and osteosarcomas are both extremely rare, and they can be difficult to differentiate histologically. Our case illustrates this difficulty and demonstrates the possibility of a high-grade osteoblastoma's malignantconversion to an osteosarcoma.
Introduction
Primary neoplasms arising within the petrous apex are rare. TIledifferential diagnosis of petrous apex tumors includes chondrosarcoma, schwannoma, paraganglioma, and primary bony tumors such as osteoblastoma and osteosarcoma.
We report the case of a 49-year-old man with a petrous apex osteoblastoma that presumably underwent malignant transformation into an osteosarcoma with subsequent distant metastasis. Theparticular rarity ofthis clinical scenario and the noted difficulty of histologically differentiating an osteoblastoma and an osteosarcoma, as well as the malignant transformation of the former to the latter, are what prompted this case report.
Case report
A 49-year-old man was referred to us for evaluation of progressive facial pain that had manifested over the course of 2.5 months. Prior to referral , he had been treated unsuccessfully with an oral antibiotic and nonsteroidal anti-inflammatory drug for presumed chronic rhinosinusitis, His pain was located predominantly over the right maxilla, and it radiated into the temple and forehead.
Notably, the patient had a history of sudden, moderate right-sided sensorineural hearing loss 1.5years prior to presentation. Findings on magnetic resonance imaging (MRI) at that time were unremarkable. Later, he noted a subjective progression of the right-sided hearing loss during the same time as the manifestation of his facial pain. Otherwise, his medical history was notable only for ulcerative colitis.
On examination, a right-sided middle ear mass was noted. The mass abutted the undersurface of the anterior 25% of the tympanic membrane. Facial nerve function was normal. Audiometric evaluation demonstrated a profound right-sided sensorineural hearing loss. Subsequent MRI and computed tomography (CT) demonstrated a destructive right petrous apex lesion with extension into the carotid canal and the medial epitympanum up to the Meckel cave. Associated bony erosion of the otic capsule was also seen. The lesion was isointense to brain on Tl-weighted imaging and hypointense on T2-weighted imaging, and it demonstrated enhancement on gadolinium contrast (figure 1). A transcanal middle ear exploration and biopsy were performed. The mass was found to be composed of both fibrous soft tissue and calcific spiculations that had the appearance of moth-eaten wood .Histologic examination identified a proliferative bony lesion. Expert pathologic consultation was obtained from multiple head and neck pathologists, including a consultation with the Armed Forces Institute of Pathology, and the consensus was that the lesion represented a high-grade osteoblastoma.
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The patient underwent a gross total resection of the tumor via a transcochlear approach. The neoplasm was found to fill the entire petrous apex and involve the intrapetrous portion of the carotid canal, but it was easily dissected from the internal carotid artery. All gross tumor was removed. As is standard with a transcochlear approach, the surgical defect was obliterated with an abdominal fat graft. The graft was harvested from the leftlower quadrant of the abdomen, and separate instruments were used.
No postoperative complications were observed, and the patient was discharged home on postoperative day 3. The tumor pathology was confirmed by multiple head and neck pathologists to be a high-grade osteoblastoma (figure 2).
One month postoperatively, the patient awoke to find he had sudden -onset right-sided facial weakness. He was treated with oral corticosteroid therapy, which Volume 95, Number 6 led to complete resolution. Temporal bone CT showed only the expected postoperative'changes. However, 1 month later, the patient developed progressive rightsided facial numbness. MRI detected mildly enhancing soft tissue that had filled the petrous apex; this finding was thought to represent either an inflammatory response or indolent petrous apicitis rather than the presence of any residual tumor. A follow-up MRI performed 1 month later showed no change.
Four months postoperatively, the patient again developed right-sided facial paresis that rapidly progressed to total paralysis. Repeat MRI and CT showed a dramatic interval mineralization of the previously noted soft tissue within the petrous apex, along with new bony destruction at the petroclival junction.
The patient was taken to the operating room for a second resection via the transcochlear approach. Based on the results of intraoperative nerve stimulation, the facial nerve appeared to have a conduction block at the geniculate ganglion, so facial nerve decompression was performed. The tumor was not amenable to en bloc resection due to involvement of the internal carotid artery and the anterior inferiorcerebellar artery. Frozensection analysis was positive for osteoblastoma. Given the significant risk of morbidity with further dissection, the decision was made to leave the gross disease behind.
No intra-or postoperative complications occurred, and the patient was discharged home on postoperative day 2. The final surgical pathology was again read by multiple head and neck pathologists as a high-grade osteoblastoma.
www.entjournal.com ·231 In view of the continued growth of the tumor, primary chemotherapy with doxorubicin combined with alternating ifosfamide and cisplatin was recommended. The patient completed 4 months of treatment. His right facial nerve function remained at House-Brackmann grade VI. Post-treatment MRI and CT showed new bony destruction near the basiocciput area, as well as destruction of the narrow space and the cortex adjacent to the foramen magnum and associated new soft-tissue enhancement. Surgery was not recommended because ofthe inability to completely remove the tumor without sacrificing the internal carotid artery and the lower cranial nerves. Proton irradiation was recommended and completed instead.
During radiation therapy, the patient developed a soft-tissue nodule in the lower left abdominal quadrant at the site of the fat graft harvest that occurred during the initial resection. The graft site had been treated as a separate surgical site during the initial operation, and there was no sharing of instruments. Fine-needle aspiration of the nodule was negative for carcinoma. However, since the nodule continued to grow, it was subsequently excised for pathologic examination. The histologic findings were examined and discussed with several pathologists, who all agreed that the lesion definitively represented an osteosarcoma rather than an osteoblastoma ( figure 3) .
The patient underwent further resection to achieve negative margins at the site of the abdominal mass. It was also recommended that he undergo additional 232 • www.entjournal.com
Figure4. ThefinalMRl (Tl-weighted,gadoliniumenhanced) shows the continuedgrowth of the lesion (arrow).
chemotherapy with high-dose methotrexate; however, that regimen was poorly tolerated, and it was discontinued early.
Post-treatment MRI showed progression of the lesion into the posterior fossa with compression of the brainstem and cerebellum. The patient was enrolled in a trial of tetrathiomolybdate, which initially led to symptom improvement. However, serial MRIs showed continued growth of the primary tumor ( figure 4) . The patient became increasingly ataxic and lethargic, and he died of the disease burden 2 years after the initial diagnosis.
Discussion
Osteoblastomas. Osteoblastomas are rare, benign bone tumors that were first categorized as distinct from osteoid osteomas in 1956, simultaneously by both Iaffe' and Lichtenstein. 2 Osteoblastomas and osteoid osteomas are histologically similar; they are distinguished by the size of the lesion.P Osteoblastomas most commonlyform in the vertebral column, the long and flatbones, and the metacarpals and metatarsals.t' Osteoblastomas of the temporal bone are exceptionally rare, as only 21 cases have been previously reported in the literature. ':"
Complete excision is considered curative for osteoblastomas, although a subtotal resection or curettage is occasionally indicated in limb preservation surgery or if the primary site is not amenable to en bloc resection . A clinical phenomenon in which the primary tumor involutes and ceases to grow has been observed after subtotal resection; this involution is believed to account for the low rate of clinical recurrence (10 to 20%).3·S The role of adjuvant radiation therapy and chemotherapyhas not been well studied. Although very rare, malignant transformation of an osteoblastoma following radiation therapy has been described."
Osteosarcomas. While osteosarcomas are the most common malignant primary bone tumor, overall they are also rare." Diagnoses are most common in adolescents, and these tumors are primarily found in the long bones; these characteristics mirror those of osteoblastoma." Primary osteosarcomas of the temporal bone are extremely rare, with very few cases reported in the literature. IS Cutaneous metastases ofosteosarcomas are also very rare. One study identified only 6 reported cases in the literature as of 2003. 16 For osteosarcomas of the extremities, treatment generally involves a wide local resection and adjuvant chemotherapyand radiation, which tends to be fairlysuecessful." In cases such as ours, a complete resection can be difficult because of the proximity of vital structures.
Histopathologic differentiation. Distinguishing an osteoblastoma and an osteosarcoma can be very difficult. Borderline tumors that exhibit radiologic and histologic features resembling both an osteoblastoma and an osteosarcoma have been reported; Dorfman and Weiss" and Lucas et aP9 used the terms aggressive osteoblastoma and high-grade osteoblastoma to describe the former. High -grade osteoblastomas are characterized byhistologic findings ofepithelioid osteoblasts, increased mitotic activity within the stromal component, and a disordered osteoid matrix. These lesions are believed to carry a higher rate of recurrence but no metastatic potential. To further complicate matters, there have been reports of malignant changes in aggressive osteoblastomas, although the rate of transformation has not been studied due to the clinical rarity of these tumors."
In conclusion, our case illustrates the diagnostic dilemma posed by these borderline tumors. It is possible that the initial tumor in our patient represented a misdiagnosed osteosarcoma at both the first and second resections. However, the results of the multidisciplinary discussions indicated that the initial tumor was indeed a high-grade osteoblastoma that had undergone malignant transformation. The malignant transformation could have been either radiation-induced or spontaneous, as both have been described. The subsequent subcutaneous metastasis in a surgical site has not been previously described in the literature.
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A pathologic review of bony tumors of the petrous apex by a head and neck pathologist might help mitigate the diagnostic challenges and help tailor therapy appropriately early in care. Primary bone neoplasms, both benign and malignant, should remain in the differential diagnosis of petrous apex lesions.
